Sign in
Stories
Pharmaceutical Companies Face Securities Lawsuits
Share
Investor Alerts: Class Action Lawsuits F...
Investor Lawsuits Impact Prominent Compa...
Investor Lawsuits: Alleged Misleading St...
AN2 Therapeutics Investigated for Securi...
Abeona Therapeutics Investigated for Vio...
AirSculpt Technologies Faces Securities ...
Overview
API
Pharmaceutical companies face class action lawsuits for alleged securities fraud and misleading investors. Bausch Health Companies Inc. and Syneos Health Companies Inc. are accused of engaging in securities fraud and misleading investors about their business prospects. Shareholders have time until September 25, 2023, to act as lead plaintiff for the class.
Ask a question
How might these class action lawsuits impact the reputation and financial stability of the pharmaceutical companies involved?
In what ways could these lawsuits influence investor confidence in the pharmaceutical industry as a whole?
What measures can pharmaceutical companies take to avoid allegations of securities fraud and misleading investors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage